Structure

InChI Key QYSGYZVSCZSLHT-UHFFFAOYSA-N
Smile FC(F)(F)C(F)(F)C(F)(F)F
InChI
InChI=1S/C3F8/c4-1(5,2(6,7)8)3(9,10)11

Physicochemical Descriptors

Property Name Value
Molecular Formula C3F8
Molecular Weight 188.02
AlogP 2.75
Hydrogen Bond Acceptor 0.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 0.0
Polar Surface Area 0.0
Molecular species None
Aromatic Rings 0.0
Heavy Atoms 11.0

Pharmacology

Action Mechanism of Action Reference
None Diagnostic agent

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Prostatic Neoplasms 3 D011471 ClinicalTrials
Prostatic Neoplasms 3 D011471 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Myocardial Infarction 2 D009203 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Carcinoma, Hepatocellular 2 D006528 ClinicalTrials
Renal Insufficiency, Chronic 2 D051436 ClinicalTrials
Cholangiocarcinoma 2 D018281 ClinicalTrials
Kidney Neoplasms 2 D007680 ClinicalTrials
Compartment Syndromes 2 D003161 ClinicalTrials
Osteosarcoma 1 D012516 ClinicalTrials
Head and Neck Neoplasms 1 D006258 ClinicalTrials
Melanoma 1 D008545 ClinicalTrials
Lymphedema 1 D008209 ClinicalTrials
Ischemic Stroke 1 D000083242 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Musculoskeletal and connective tissue disorders
22.15
General disorders and administration site conditions
11.28
Nervous system disorders
10.83
Skin and subcutaneous tissue disorders
9.58
Cardiac disorders
9.54
Respiratory, thoracic and mediastinal disorders
9.03
Vascular disorders
7.27
Immune system disorders
4.89
Gastrointestinal disorders
4.59
Investigations
3.15
Psychiatric disorders
2.35

Cross References

Resources Reference
CAS NUMBER 76-19-7
ChEBI 31980
ChEMBL CHEMBL1663
DrugBank DB00556
DrugCentral 2104
EPA CompTox DTXSID9052503
FDA SRS CK0N3WH0SR
Human Metabolome Database HMDB14696
PharmGKB PA164781354
PubChem 6432
SureChEMBL SCHEMBL34348
ZINC ZINC000008214651